James M. Daly

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James M. Daly:

Company Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 2,627 $877,181 $333.91 20 Jun 2025 Direct
HALOZYME THERAPEUTICS, INC. Director Common Stock 20,503 $738,108 $36.00 14 Aug 2023 Direct
ACADIA PHARMACEUTICALS INC Director Restricted Stock Units 8,107 $159,016 $16.94 29 May 2025 Direct
HALOZYME THERAPEUTICS, INC. Director Option to Purchase Common Stock 11,371 $157,716 $13.87 05 May 2023 Direct
ACADIA PHARMACEUTICALS INC Director Common Stock 4,041 $90,381 $22.37 10 Nov 2025 Direct
BELLICUM PHARMACEUTICALS, INC Director Stock Option (right to buy) 15,000 $21,600 $1.44 15 Jun 2022 Direct
BELLICUM PHARMACEUTICALS, INC Director Common Stock 109,873 03 Jan 2023 Direct
CYTOKINETICS INC Director Non-Qualified Stock Option (Right to Buy) 27,450 19 Aug 2025 Direct
ACADIA PHARMACEUTICALS INC Director Director Stock Options (Right to Buy) 13,793 29 May 2025 Direct
MADRIGAL PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 1,290 20 Jun 2025 Direct
BELLICUM PHARMACEUTICALS, INC Director Restricted Stock Units 0 04 Jan 2022 Direct

Insider Reports Filed by James M. Daly

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACAD ACADIA PHARMACEUTICALS INC 10 Nov 2025 1 -$670,983 4 Director 12 Nov 2025, 18:00
CYTK CYTOKINETICS INC 19 Aug 2025 1 $0 4 Director 20 Aug 2025, 08:04
CYTK CYTOKINETICS INC 19 Aug 2025 0 $0 3 Director 20 Aug 2025, 07:58
MDGL MADRIGAL PHARMACEUTICALS, INC. 20 Jun 2025 2 $0 4 Director 24 Jun 2025, 16:34
ACAD ACADIA PHARMACEUTICALS INC 29 May 2025 4 $0 4 Director 02 Jun 2025, 18:05
MDGL MADRIGAL PHARMACEUTICALS, INC. 27 Feb 2025 7 -$4,092,647 4 Director 28 Feb 2025, 16:31
MDGL MADRIGAL PHARMACEUTICALS, INC. 25 Jun 2024 2 $0 4 Director 27 Jun 2024, 21:42
ACAD ACADIA PHARMACEUTICALS INC 29 May 2024 4 $0 4 Director 31 May 2024, 18:00
MDGL MADRIGAL PHARMACEUTICALS, INC. 01 Apr 2024 22 -$4,897,286 4 Director 03 Apr 2024, 20:41
HALO HALOZYME THERAPEUTICS, INC. 11 Aug 2023 2 -$874,520 4 Director 15 Aug 2023, 17:04
MDGL MADRIGAL PHARMACEUTICALS, INC. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 18:41
HALO HALOZYME THERAPEUTICS, INC. 05 May 2023 2 $0 4 Director 09 May 2023, 18:14
/report/000162828023000422-daly-james-m-2023-01-03 BELLICUM PHARMACEUTICALS, INC 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 12:12
/report/000162828022024219-daly-james-m-2022-09-01 BELLICUM PHARMACEUTICALS, INC 01 Sep 2022 1 $0 4 Director 02 Sep 2022, 10:30
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 06:30
/report/000162828022017338-daly-james-m-2022-06-15 BELLICUM PHARMACEUTICALS, INC 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 14:46
ACAD ACADIA PHARMACEUTICALS INC 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 20:30
HALO HALOZYME THERAPEUTICS, INC. 05 May 2022 1 $0 4 Director 06 May 2022, 20:05
/report/000162828022000412-daly-james-m-2022-01-04 BELLICUM PHARMACEUTICALS, INC 04 Jan 2022 4 $0 4 Director 06 Jan 2022, 08:39
/report/000120919121045705-daly-james-m-2021-07-01 BELLICUM PHARMACEUTICALS, INC 01 Jul 2021 1 $0 4 Director 06 Jul 2021, 20:28
ACAD ACADIA PHARMACEUTICALS INC 22 Jun 2021 8 $0 4 Director 05 Jun 2023, 21:38
ACAD ACADIA PHARMACEUTICALS INC 22 Jun 2021 2 $0 4 Director 24 Jun 2021, 16:39
MDGL MADRIGAL PHARMACEUTICALS, INC. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 08:03
/report/000120919121045940-daly-james-m-2021-06-15 BELLICUM PHARMACEUTICALS, INC 15 Jun 2021 1 $0 4 Director 07 Jul 2021, 20:23